Advanced search
Publication Cover
International Medical Case Reports Journal Volume 15, 2022 - Issue
Submit an article Journal homepage
136
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Long-Acting Fluocinolone Acetonide Intravitreal Implant for Recurrent Bilateral Non-Infectious Posterior Uveitis

Adrian T Babel1 Boonshoft School of Medicine, Dayton, OH, USA;2 Erie Retinal Surgery, Erie, PA, USA
,
Eric K Chin3 Retina Consultants of Southern California, Redlands, CA, USA;4 Loma Linda Eye Institute, Veterans Affair Hospital, Loma Linda, CA, USAORCID Iconhttps://orcid.org/0000-0003-2274-8194
ORCID Icon &
David RP Almeida2 Erie Retinal Surgery, Erie, PA, USACorrespondence[email protected]
Pages 665-669 | Received 02 Aug 2022, Accepted 10 Nov 2022, Published online: 22 Nov 2022

References

  • Takeuchi M, Mizuki N, Ohno S. Pathogenesis of non-infectious uveitis elucidated by recent genetic findings. Front Immunol. 2021;12:640473. doi:10.3389/fimmu.2021.640473
  • Massa H, Pipis SY, Adewoyin T, Vergados A, Patra S, Panos GD. Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges. Clin Ophthalmol. 2019;13:1761–1777. doi:10.2147/OPTH.S180580
  • Huang XF, Brown MA. Progress in the genetics of uveitis. Genes Immun. 2022;23(2):57–65. doi:10.1038/s41435-022-00168-6
  • Kempen JH, Altaweel MM; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Benefits of systemic anti-inflammatory therapy versus fluocinolone acetonide intraocular implant for intermediate uveitis, posterior uveitis, and panuveitis: fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) trial and follow-up study. Ophthalmology. 2015;122(10):1967–1975. doi:10.1016/j.ophtha.2015.06.042
  • Kuppermann BD, Zacharias LC, Kenney MC. Steroid differentiation: the safety profile of various steroids on retinal cells in vitro and their implications for clinical use (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2014;112:116–141.
  • Testi I, Pavesio C. Preliminary evaluation of YUTIQ™ (fluocinolone acetonide intravitreal implant 0.18 mg) in posterior uveitis. Ther Deliv. 2019;10(10):621–625. doi:10.4155/tde-2019-0051
  • Uveitis treatment. Fluocinolone acetonide intravitreal implant. YUTIQ®. Available from: https://yutiq.com/downloads/YUTIQ%20Patient%20Brochure_21070601.pdf. Accessed June 7, 2022.
  • Thorne JE, Suhler E, Skup M, et al. Prevalence of non-infectious uveitis in the United States: a claims-based analysis. JAMA Ophthalmol. 2016;134(11):1237–1245. doi:10.1001/jamaophthalmol.2016.3229
  • Tan HY, Agarwal A, Lee CS, et al. Management of non-infectious posterior uveitis with intravitreal drug therapy. Clin Ophthalmol. 2016;10:1983–2020. doi:10.2147/OPTH.S89341
  • Arcinue CA, Cerón OM, Foster CS. A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis. J Ocul Pharmacol Ther. 2013;29(5):501–507. doi:10.1089/jop.2012.0180
  • Jaffe GJ, Pavesio CE; Study Investigators. Effect of a fluocinolone acetonide insert on recurrence rates in noninfectious intermediate, posterior, or panuveitis: three-year results. Ophthalmology. 2020;127(10):1395–1404. doi:10.1016/j.ophtha.2020.04.001
  • Safety and efficacy study of a FAI insert in subjects with chronic non-infectious posterior uveitis - study results. Study Results - ClinicalTrials.gov. Available from: https://clinicaltrials.gov/ct2/show/results/NCT02746991. Accessed September 27, 2022.
  • Liao W, Zhong Z, Su G, Feng X, Yang P. Comparative efficacy and safety of advanced intravitreal therapeutic agents for noninfectious uveitis: a systematic review and network meta-analysis. Front Pharmacol. 2022;13:749312. doi:10.3389/fphar.2022.749312

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.